Sberbank has created a pharmaceutical company

Sberbank, founded the company “Immunotechnology”, the main activities which will be the wholesale trade of pharmaceutical products, pharmaceutical substances, medicinal preparations and scientific research and development in biotechnology. The company was registered on 15 may, 100% of it belongs to the savings Bank, with registered capital of 50 million rubles, write “Vedomosti”.

The General Director of the company has appointed Dmitry Efimov, the former General Director “Nizhfarm” and senior Vice President of Stada CIS. Now he, according to SPARK, a member of the Board of Directors Medicalinstrument plant. V. I. Lenin Nizhny Novgorod and Nizhny Novgorod pharmacy network.

Sberbank also offered its employees to volunteer in the testing of vaccines against coronavirus. About it reported mass media with reference to the copy of the letter was provided to employees of the Bank. It lists the requirements for volunteers and contraindications to participation in the program.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]